Nucleate Recognized as One of America's Best Incubators and Accelerators by TIME

Nucleate, the global nonprofit dedicated to helping early-career scientists transform their academic research into biotech ventures, has received recognition from TIME as one of America's Best Incubators and Accelerators. This accolade was part of the publication's inaugural national ranking, revealed during the Nucleate Global Summit 2026, which took place from August 16 to 18 at Southfork Ranch near Dallas. The summit attracted over 600 founders, scientists, investors, and industry leaders from more than 15 countries to engage in discussions about the future of biotechnology.

The rankings were produced in collaboration with data firm Statista, which assessed thousands of programs across the nation. The evaluation primarily relied on feedback from founders and alumni, with 85% of each program's score based on a survey of over 2,000 founders who participated in incubators and accelerators from 2020 to 2025. The remaining 15% was determined by the success of each program's top startups and recommendations from investors and seasoned entrepreneurs.

"Our Activator alumni founders are the ones who decided this ranking, and that is the part that matters to me," stated Oliver Dodd, Co-Founder and Executive Director of Nucleate. He emphasized the organization's mission: "We started Nucleate because too many early-career scientists could see the potential of their discoveries, but not the path to turn them into something that could reach patients. We set out to build that path. This recognition is powerful validation that it's working."

The Activator, Nucleate's flagship program, is designed to be free for participants and does not require equity. It provides a structured pathway for scientists to transition from research projects to established companies, featuring co-founder matching, mentorship from industry veterans, and a comprehensive curriculum aimed at helping early-stage founders develop their scientific plans and business cases. The 2026 Activator cohort was notably competitive, with 180 teams chosen from over 2,200 applicants across more than 400 academic institutions, supported by 600 industry experts matched to teams by field.

"It's a forcing function," remarked Gleb Kuznetsov, CEO of Manifold Bio. "You go from postdoc to founder by getting out of the lab and testing your plan against reality. Nucleate gives you the framework."

For aspiring scientists and biotech leaders looking to advance their careers, Nucleate invites academic researchers worldwide to apply for the 2027 Activator, where they can lay the groundwork for their companies and connect with a global community of founders. Applications are currently open, and those interested can apply to the 2027 Nucleate Activator or find ways to engage with Nucleate in their region at https://gateway.nucleate.org/.

About Nucleate: Nucleate is a 501(c)(3) nonprofit that empowers the next generation of biotech leaders through free, open-access innovation programs, mentorship, and community. Learn more at nucleate.org.